Is embryo selection allowing parents to ‘build-a-baby’?
Summary
BBC’s The Global Story explores the ethics of embryo genetic screening with Professor Adam Rutherford, prompted by reports that Elon Musk used startup Orchid Health. Rutherford critiques the science behind predicting complex traits like intelligence, calling it spurious, while distinguishing modern parental choice from historical state-imposed eugenics. The episode balances the benefits of preventing monogenic diseases against the risks of commercial hype and false hope.
Topics discussed
Sponsors and podcast introduction
Elon Musk and Orchid Health embryo screening
Introduction of Professor Adam Rutherford
Scientific validity of polygenic disease screening
History of IVF and embryo selection technology
Critique of decoupling sex from reproduction
Predicting traits like eye color and intelligence
Ethical issues of sex selection in embryos
Charles Schwab advertisement
Comparison of modern screening to historical eugenics
Benefits of genetic counseling and gene therapy
Hope for gene therapy and risks of commercialization
Closing remarks and credits
Listen ad-free on Castria